Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia

被引：2
|
作者：
Strati, Paolo [1 ]
Ferrajoli, Alessandra [1 ]
Wierda, William G. [1 ]
Jain, Nitin [1 ]
Thompson, Philip A. [1 ]
O'Brien, Susan M. [1 ]
Rezvani, Katy [1 ]
Kantarjian, Hagop M. [1 ]
Burger, Jan A. [1 ]
Hinojosa, Christina O. [1 ]
Keating, Michael J. [1 ]
Estrov, Zeev [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
LEUKEMIA | 2018年 / 32卷 / 10期
关键词：
1ST-LINE THERAPY; CELLS; RITUXIMAB; CLL; CYCLOPHOSPHAMIDE; FLUDARABINE; OUTCOMES;
D O I：
10.1038/s41375-018-0059-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2278 / 2281
页数：4
相关论文
共 50 条
  • [21] Lenalidomide in lymphomas and chronic lymphocytic leukemia
    Wiernik, Peter H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (04) : 475 - 488
  • [22] Lenalidomide in the treatment of chronic lymphocytic leukemia
    Gentile, Massimo
    Recchia, Anna Grazia
    Vigna, Ernesto
    Mazzone, Carla
    Lucia, Eugenio
    Gigliotti, Vincenzo
    Bossio, Sabrina
    Madeo, Antonio
    Morabito, Lucio
    Servillo, Pasquale
    Franzese, Stefania
    Caruso, Nadia
    De Stefano, Laura
    Bisconte, Maria Grazia
    Gentile, Carlo
    Morabito, Fortunato
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (02) : 273 - 286
  • [23] Is there a sustained response following discontinuation of long-lasting anti-CGRP monoclonal antibodies treatment?
    Cetta, I.
    Messina, R.
    Zanandrea, L.
    Guerrieri, S.
    Vaghi, G.
    De Icco, R.
    Sances, G.
    Colombo, B.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 153 - 153
  • [24] Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia
    Badoux, Xavier C.
    Keating, Michael J.
    Wen, Sijin
    Lee, Bang-Ning
    Sivina, Mariela
    Reuben, James
    Wierda, William G.
    O'Brien, Susan M.
    Faderl, Stefan
    Kornblau, Steven M.
    Burger, Jan A.
    Ferrajoli, Alessandra
    BLOOD, 2011, 118 (13) : 3489 - 3498
  • [25] Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia
    Maurer, Christian
    Pflug, Natali
    Bahlo, Jasmin
    Kluth, Sandra
    Rhein, Christina
    Cramer, Paula
    Gross-Ophoff, Carolin
    Langerbeins, Petra
    Fink, Anna-Maria
    Eichhorst, Barbara
    Kreuzer, Karl-Anton
    Fischer, Norbert
    Tausch, Eugen
    Stilgenbauer, Stephan
    Boettcher, Sebastian
    Doehner, Hartmut
    Kneba, Michael
    Dreyling, Martin
    Binder, Mascha
    Hallek, Michael
    Wendtner, Clemens-Martin
    Bergmann, Manuela
    Fischer, Kirsten
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (03) : 253 - 260
  • [26] Lenalidomide active in patients with refractory or relapsed chronic lymphocytic leukemia
    Nature Clinical Practice Oncology, 2007, 4 (3): : 143 - 143
  • [27] Long lasting molecular changes before diagnosis of chronic lymphocytic leukemia
    Frezzato, M
    Giaretta, I
    Madeo, D
    Rodeghiero, F
    ANNALS OF ONCOLOGY, 2005, 16 : 90 - 91
  • [28] Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
    Vitale, Candida
    Falchi, Lorenzo
    ten Hacken, Elisa
    Gao, Hui
    Shaim, Hila
    Van Roosbroeck, Katrien
    Calin, George
    O'Brien, Susan
    Faderl, Stefan
    Wang, Xuemei
    Wierda, William G.
    Rezvani, Katayoun
    Reuben, James M.
    Burger, Jan A.
    Keating, Michael J.
    Ferrajoli, Alessandra
    CLINICAL CANCER RESEARCH, 2016, 22 (10) : 2359 - 2367
  • [29] Lenalidomide Alone and in Combination for Chronic Lymphocytic Leukemia
    Christine I. Chen
    Current Hematologic Malignancy Reports, 2013, 8 : 7 - 13
  • [30] Treating chronic lymphocytic leukemia with thalidomide and lenalidomide
    Giannopoulos, Krzysztof
    Mertens, Daniel
    Stilgenbauer, Stephan
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (18) : 2857 - 2864
12345